Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2333 studies found for:    pancreatic cancer
Show Display Options
Rank Status Study
21 Recruiting A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer
Conditions: Pancreatic Cancer;   Hypoxia
Intervention:
22 Withdrawn GI-4000 With Adoptive Transfer in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Other: Screening;   Biological: GI-4000 Vaccine;   Biological: GI-4000 Vaccine + Activated T Cells;   Biological: Surgical Evaluation after Vaccine #4
23 Completed
Has Results
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Dose level 1;   Drug: Dose level 2/MTD;   Drug: Dose level 3
24 Completed Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Biological: bavituximab;   Drug: Gemcitabine
25 Recruiting Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Condition: Pancreatic Tumor
Intervention: Procedure: suspected pancreatic tumor
26 Completed Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Carcinoma
Condition: Pancreatic Cancer
Intervention: Procedure: interventional therapy
27 Recruiting Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: NK cells;   Procedure: irreversible electroporation (IRE )
28 Active, not recruiting Stool Testing for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
29 Active, not recruiting Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples
Condition: Gastric and Pancreatic Cancer
Intervention: Other: washings for experimental marker testing
30 Completed Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Radiation: MeIQx;   Procedure: Pancreatectomy
31 Completed
Has Results
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Condition: Pancreatic Cancer
Intervention: Biological: GVAX pancreatic cancer vaccine
32 Recruiting Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
Condition: Pancreatic Cancer
Intervention: Drug: Gadobutrol
33 Completed Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis
Conditions: Pancreatic Cancer;   Precancerous Condition
Intervention:
34 Active, not recruiting Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Condition: Pancreatic Cancer
Intervention: Biological: allogenic GM-CSF plasmid-transfected pancreatic tumor cell vaccine
35 Active, not recruiting Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: S-1;   Radiation: Radiation Therapy
36 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Drug: OMP-54F28, Nab-Paclitaxel and Gemcitabine
37 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Vantictumab;   Drug: Nab-Paclitaxel;   Drug: Gemcitabine
38 Recruiting Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Device: NanoKnife LEDC System
39 Enrolling by invitation A Study of Locally Advanced Pancreatic Cancer
Condition: Locally Advanced Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Gemcitabine, Oxaliplatin, 5-Fluorouracil, Leucovorin (GOFL)
40 Completed Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: FOLFIRINOX;   Genetic: Immunohistochemistry (IHC) Analysis;   Drug: Metformin;   Drug: mFOLFIRI

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.